Comparison of Intensive Treatment Regimens and Standard Treatment Regimen for Tuberculous Meningitis: Pharmacokinetics, Pharmacodynamics and Tolerability Study.
Phase of Trial: Phase II
Latest Information Update: 01 Jan 2013
At a glance
- Drugs Moxifloxacin (Primary) ; Rifampicin (Primary) ; Rifampicin (Primary) ; Ethambutol
- Indications Tubercular meningitis
- Focus Pharmacokinetics
- 06 Jun 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 03 Apr 2012 Interim results presented at the 22nd European Congress of Clinical Microbiology and Infectious Diseases.
- 15 Dec 2011 Additional trial investigator identified as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History